Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.
Lancet Neurol. 2022 Jan;21(1):66-77. doi: 10.1016/S1474-4422(21)00361-6. Epub 2021 Nov 24.
Lancet Neurol. 2022.
PMID: 34838239
Review.